as on September 16, 2025 at 11:38 pm IST
Day's Low
Day's High
5.68%
Downside
1.06%
Upside
52 Week's Low
52 Week's High
50.33%
Downside
287.05%
Upside
Check Myriad Genetics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$680.2M
EPS (TTM)
0.0071
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.57
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
1.4001
EBITDA
-17.8M
Revenue (TTM)
832.9M
Profit Margin
-47.45%
Return On Equity TTM
16851600.00%
Track how Myriad Genetics Inc. P/E has moved over time to understand its valuation trends.
Myriad Genetics Inc. in the last 5 years
Lowest (53.70x)
June 30, 2025
Today (-16.57x)
September 16, 2025
Industry (10.13x)
September 16, 2025
Highest (193.36x)
September 30, 2024
Today’s Price to Earnings Ratio: -16.57x
Compare market cap, revenue, PE, and other key metrics of Myriad Genetics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $680.2M | -44.48% | -16.57 | -47.45% | |
BUY | $51.5B | 77.72% | 53.49 | 24.41% | |
BUY | $35.6B | 25.73% | 28.81 | 17.97% | |
BUY | $31.8B | 14.79% | 27.11 | 7.88% | |
BUY | $181.1B | 9.35% | 27.7 | 15.24% |
The Myriad Genetics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Myriad Genetics Inc. investment value today
Current value as on today
₹32,000
Returns
Returns from Myriad Genetics Inc. Stock
Dollar Returns*
₹4,867 (+4.87%)
Based on 18 analysts
50.00%
Buy
33.33%
Hold
16.67%
Sell
Based on 18 analysts, 50% of analysts recommend a 'BUY' rating for Myriad Genetics Inc.. Average target price of $7.38
Get share price movements and forecasts by analysts on Myriad Genetics Inc..
What analysts predicted
-2.57%DOWNSIDE
Target Price
$7.38
Current Price
$7.57
Analyzed by
18 Analysts
Target
$7.38
Myriad Genetics Inc. target price $7.38, a slight downside of -2.57% compared to current price of $7.57. According to 18 analysts rating.
Search interest for Myriad Genetics Inc. Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, MYGN stock has moved up by 28.0%
Revenue Rich
Revenue is up for the last 2 quarters, 195.9M → 213.1M (in $), with an average increase of 8.1% per quarter
Against Peers
In the last 1 year, Idexx Laboratories, Inc. has given 25.9% return, outperforming this stock by 99.7%
Against Peers
In the last 3 years, Idexx Laboratories, Inc. has given 88.0% return, outperforming this stock by 153.8%
Profit Down
Netprofit is down for the last 2 quarters, -100.0K → -330.5M (in $), with an average decrease of 330400.0% per quarter
Organisation | Myriad Genetics Inc. |
Headquarters | 322 North 2200 West, Salt Lake City, UT, United States, 84116 |
Industry | Health Technology |
CEO | Mr. Samraat S. Raha |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Samraat S. Raha | President, CEO & Director |
Mr. Mark S. Verratti | Chief Operating Officer |
Mr. Paul J. Diaz J.D. | Consultant & Director |
Mr. Ben Wheeler | Chief Financial Officer |
Mr. Matthew Scalo | Senior Vice President of Investor Relations |
Ms. Shereen Solaiman | Chief People Officer |
Dr. Dale Muzzey Ph.D. | Chief Scientific Officer |
Ms. Natalie Munk | Senior VP & Chief Accounting Officer |
Dr. Kevin Richard Haas Ph.D. | Chief Technology Officer |
Ms. Jennifer L. Fox J.D. | Chief Legal Officer |
Myriad Genetics Inc. share price today is $7.57 as on . Myriad Genetics Inc. share today touched a day high of $7.65 and a low of $7.14.
Myriad Genetics Inc. share touched a 52 week high of $29.3 on and a 52 week low of $3.76 on . Myriad Genetics Inc. stock price today i.e. is trending at $7.57,which is 74.16% down from its 52 week high and 101.33% up from its 52 week low.
Myriad Genetics Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Myriad Genetics Inc. (MYGN) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Myriad Genetics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Myriad Genetics Inc. share’s latest price of $7.57 as on September 16, 2025 at 11:38 pm IST, you will get 1.3210 shares of Myriad Genetics Inc.. Learn more about
fractional shares .
Myriad Genetics Inc. stock has given -44.48% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?